|IN THIS ISSUE|
|SPOTLIGHT 1 OF THE WEEK||SPOTLIGHT 2 OF THE WEEK|
A How to Guide to Hike Prices and Lower Tax Liability-from Pfizer.
A Closer Look at Pharmaceutical Brand Spending.
Has ObamaCare Lowered Your Standard of Living?
5 Ways to Tell a Story with Data.
The Current and Projected Taxpayer Shares of US Health Costs.
Do Observational Studies Exaggerate RT Benefits in Breast Cancer?
Can Pharma Fix Its Reputation?
Podcast: the Pharmacist Entrepreneur.
Customer-driven Strategies for Health Care Professionals.
Specialty Drugs Among Most Common FDA Approvals in 2015.
|Link of the Week||Conference of the Week||Webinar of the Week|